Funding Landscape

Open grants: tool development molecular closing within 30 days

As of November 21, 2026, a Funding Landscape search for open grants about "tool development molecular" closing in the next 30 days found 5 listings. 5 close within 30 days, the first on November 23, 2026. Confirm deadlines and eligibility on each official notice before applying.

  1. 1. Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

  2. 2. Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

  3. 3. NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)

    • Type: Grant
    • Funder or buyer: National Institutes of Health
    • Deadline:
    • Who can apply: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the...
    • Place: Location not confirmed; check the notice
    • Summary: The purpose of this notice of funding opportunity (NOFO) is to provide salary support for exceptional Research Software Engineers (RSEs) that contribute their skills to the development and dissemination of biomedical,...
    • Official notice: https://www.grants.gov/search-results-detail/355439
    • Listing: https://fundinglandscape.com/opportunity/cmj9dd4n6007fju04lob54uim
  4. 4. AACR-Kids Beating Cancer Margaret Guedes Monosomy 7 Legacy Cancer Research Grant

    • Type: Grant
    • Funder or buyer: American Association for Cancer Research (AACR)
    • Deadline:
    • Amount: Up to $300,000 per award
    • Who can apply: At the start of the grant term (April 1, 2027), applicants must: Have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field. Be independent (non-mentored) investigators. If eligibility is based on a...
    • Place: Location not confirmed; check the notice
    • Summary: Despite advances in the molecular characterization and treatment of acute myeloid leukemia (AML), outcomes remain poor for patients with adverse cytogenetic features. Monosomy 7 AML, whether occurring in pediatric or...
    • Official notice: https://www.aacr.org/grants/aacr-kids-beating-cancer-margaret-guedes-monosomy-7-legacy-cancer-research-grant/
    • Listing: https://fundinglandscape.com/opportunity/c9e68f9a-90e5-417b-af02-863dba09572c
    • Last verified against the source:
  5. 5. Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

    • Type: Grant
    • Funder or buyer: National Institutes of Health
    • Deadline:
    • Amount: Up to $2,000,000 per award
    • Place: Location not confirmed; check the notice
    • Summary: The National Human Genome Research Institute (NHGRI) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for research to characterize genomic variation to...
    • Official notice: https://www.grants.gov/search-results-detail/358854
    • Listing: https://fundinglandscape.com/opportunity/cmh3qc7ti009oleppds256dms

Coverage notes

Related questions

Source: Funding Landscape, https://fundinglandscape.com/open?q=tool+development+molecular&kind=grants&due=30

Get new matches for this search by email: https://fundinglandscape.com/save?q=tool+development+molecular&kind=grant&due=30&source=open-answer

Free accounts can search for listings 10 days after they launch if still open. Plus and Pro can search for listings on launch day. Alert emails follow your selected schedule. See pricing